-
31.发明授权Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them 失效三环化合物及其在药物制备中的应用及含有它们的药物组合物公开(公告)号：US06548666B1
公开(公告)日：2003-04-15
申请号：US09853176
申请日：2001-05-10
申请人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Ashok Channaveerappa Bajji , Shivaramayya Kalchar , Rao Bheema Paraselli , Ranga Madhavan Gurram
发明人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Ashok Channaveerappa Bajji , Shivaramayya Kalchar , Rao Bheema Paraselli , Ranga Madhavan Gurram
IPC分类号： C07D2448
CPC分类号： C07D413/06 , C07C59/64 , C07C69/734 , C07D265/28 , C07D265/38 , C07D279/22 , C07D279/26 , C07D417/06
摘要： A compound of Formula (Ig) The compounds may be used, inter alia, for preparing beta aryl-alpha-oxy substituted alkylcarboxylic acids.
摘要翻译： 式（Ig）的化合物该化合物尤其用于制备β芳基-α-氧取代的烷基羧酸。
-
32.发明授权Tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them 失效三环化合物及其在医药中的应用 其制备方法和含有它们的药物组合物公开(公告)号：US06608194B1
公开(公告)日：2003-08-19
申请号：US09853177
申请日：2001-05-10
申请人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Ashok Channaveerappa Bajji , Shivaramayya Kalchar , Rao Bheema Paraselli , Ranga Madhavan Gurram
发明人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Ashok Channaveerappa Bajji , Shivaramayya Kalchar , Rao Bheema Paraselli , Ranga Madhavan Gurram
IPC分类号： C07D26538
CPC分类号： C07D413/06 , C07C59/64 , C07C69/734 , C07D265/28 , C07D265/38 , C07D279/22 , C07D279/26 , C07D417/06
摘要： A compound of Formula (Ih) The compounds may be used, inter alia, for preparing beta aryl-alpha-oxy substituted alkylcarboxylic acids.
摘要翻译： 式（Ih）的化合物该化合物尤其用于制备β芳基-α-氧取代的烷基羧酸。
-
33.发明授权Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them 失效苯并咪唑衍生物作为抗溃疡剂，其制备方法和含有它们的药物组合物
公开(公告)号：US6051570A
公开(公告)日：2000-04-18
申请号：US41191
申请日：1998-03-10
申请人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Prasuna Guntupalli , Narayan Reddy Kommireddi , Prem Kumar Mamnoor , Rajagopalan Ramanujam
发明人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Prasuna Guntupalli , Narayan Reddy Kommireddi , Prem Kumar Mamnoor , Rajagopalan Ramanujam
IPC分类号： C07D491/113 , A61K31/4439 , A61K31/4545 , A61K31/496 , A61K31/5377 , A61K31/55 , A61P1/04 , C07D235/28 , C07D401/12 , C07D401/14 , C07D491/10 , C07D491/107 , C07D521/00 , A61K31/535 , C07D403/14 , C07D413/14
CPC分类号： C07D231/12 , C07D233/56 , C07D235/28 , C07D249/08 , C07D401/12 , C07D401/14 , C07D491/10
摘要： This invention particularly relates to novel pyridylmethylsulfinyl benzimidazole represented by the general formula (I), its tautomers, its derivatives, its analogs, its stereoisomers, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates and pharmaceutical compositions containing them and the use thereof. ##STR1## The present invention also relates to a process for the preparation of the above said novel pyridylmethylsulfinyl benzimidazoles and pharmaceutical compositions containing them.
摘要翻译： 本发明特别涉及由通式（I）表示的新型吡啶基甲基亚磺酰基苯并咪唑，其互变异构体，其衍生物，其类似物，其立体异构体，其多晶型物，其药学上可接受的盐，其药学上可接受的溶剂合物和含有它们的药物组合物及其用途 。 本发明还涉及制备上述新的吡啶基甲基亚磺酰基苯并咪唑的方法和含有它们的药物组合物。
-
34.发明授权Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine 有权具有降血脂低胆固醇活性的吡咯，其制备方法和含有它们的药物组合物及其在药物中的用途公开(公告)号：US08558009B2
公开(公告)日：2013-10-15
申请号：US13066807
申请日：2011-04-25
申请人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Vijay Kumar Barot , Saurin Khimshankar Raval , Preeti Saurin Raval , Sujay Basu
发明人： Braj Bhushan Lohray , Vidya Bhushan Lohray , Vijay Kumar Barot , Saurin Khimshankar Raval , Preeti Saurin Raval , Sujay Basu
IPC分类号： C07D207/30 , A61K31/40
CPC分类号： C07D207/325 , C07D207/33 , C07D207/333 , C07D207/335 , C07D207/36 , C07D207/48 , C07D401/04 , C07D405/04 , C07D409/04 , G06F3/14 , G06F3/1438 , G09G5/363 , G09G2360/122
摘要： The present invention relates to compounds of the general formula (I) their derivatives, their analogs, their tautomeric forms, their pharmaceutically acceptable salts, wherein all variables are as defined in the specification.
摘要翻译： 本发明涉及通式（I）化合物的衍生物，它们的类似物，它们的互变异构形式及其药学上可接受的盐，其中所有变量如说明书中所定义。
-
公开(公告)号：US08053579B2
公开(公告)日：2011-11-08
申请号：US12760523
申请日：2010-04-14
IPC分类号： C07D513/02
CPC分类号： C07D495/04
摘要： Disclosed are new salts of Clopidogrel viz. Clopidogrel mesylate, Clopidogrel besylate and Clopidogrel tosylate, methods for their preparation and pharmaceutical compositions containing them and their use in medicine.
摘要翻译： 公开了氯吡格雷的新盐 甲磺酸氯吡格雷，苯磺酸氯吡格雷和甲磺酸氯吡格雷，其制备方法和含有它们的药物组合物及其在医学中的应用。
-
公开(公告)号：US07863300B2
公开(公告)日：2011-01-04
申请号：US12010473
申请日：2008-01-25
IPC分类号： A61K31/4436 , C07D417/12
CPC分类号： C07D213/30 , C07D213/34 , C07D417/12
摘要： A novel process for preparing thiazolidinediones, preferably Pioglitazone, as described. Also described are novel intermediates involved in its synthesis and process for their preparation and use in medicine.
摘要翻译： 如所述制备噻唑烷二酮类，优选吡格列酮的新方法。 还描述了涉及其合成的新型中间体及其在医药中的制备和应用的方法。
-
37.发明申请公开(公告)号：US20100273791A1
公开(公告)日：2010-10-28
申请号：US12769861
申请日：2010-04-29
IPC分类号： A61K31/416 , C07D231/54 , C07D491/044 , C07D495/04 , A61K31/454 , A61K31/4162 , A61K31/5377 , A61K31/496 , C07C69/738 , C07D313/08 , C07D337/08
CPC分类号： C07D495/14 , C07D495/04
摘要： The present invention relates to novel compounds of general formula (I), their regioisomers, tautomeric forms, novel intermediates involved in their synthesis. The present invention also relates to a process of preparing compounds of general formula (I), their regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.
摘要翻译： 本发明涉及通式（I）的新型化合物，其区域异构体，互变异构体，涉及其合成的新型中间体。 本发明还涉及制备通式（I）的化合物，其区域异构体，其互变异构形式，其药学上可接受的盐，含有它们的药物组合物以及参与其合成的新中间体的方法。
-
公开(公告)号：US20090192191A1
公开(公告)日：2009-07-30
申请号：US10585420
申请日：2005-01-07
IPC分类号： A61K31/4709 , C07D401/12 , C07D207/38 , C07D405/14 , C07D409/14 , A61K31/4015 , A61P19/02
CPC分类号： C07D409/14 , C07D401/12 , C07D405/14
摘要： The present invention relates to novel compounds of formula (I) and their pharmaceutically useful compositions as MMP and TNF inhibitors.
摘要翻译： 本发明涉及新的式（I）化合物及其药学上有用的组合物作为MMP和TNF抑制剂。
-
公开(公告)号：US20090171091A1
公开(公告)日：2009-07-02
申请号：US12374089
申请日：2007-07-27
IPC分类号： C07D215/48
CPC分类号： C07C237/30 , C07C2601/14 , C07D215/48 , C07D405/12
摘要： Disclosed herein in the embodiments of the present invention are the compounds suitable as modulators of HDL having general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to a process of preparing compounds of general formula (1), their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.
摘要翻译： 在本发明的实施方案中公开的是适合作为具有通式（1）的HDL的调节剂的化合物，涉及其合成的新中间体，其药学上可接受的盐和含有它们的药物组合物。 本发明还涉及制备通式（1）的化合物，其互变异构形式，其药学上可接受的盐，含有它们的药物组合物和参与其合成的新中间体的方法。
-
40.发明授权Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases 失效杂环化合物，其制备方法和含有它们的药物组合物及其在治疗糖尿病和相关疾病中的用途
公开(公告)号：US5885997A
公开(公告)日：1999-03-23
申请号：US777627
申请日：1996-12-31
IPC分类号： C07D413/12 , C07D417/12 , C07D471/04 , C07D495/04 , A61K31/425
CPC分类号： C07D413/12 , C07D417/12 , C07D471/04 , C07D495/04
摘要： The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. ##STR1##
摘要翻译： 本发明涉及新的抗糖尿病化合物，其互变异构形式，其衍生物，其立体异构体，其多晶型物，其药学上可接受的盐，其药学上可接受的溶剂合物和含有它们的药学上可接受的组合物。 本发明特别涉及通式（I）的新的唑来二酮衍生物及其药学上可接受的盐，药学上可接受的溶剂合物和含有它们的药物组合物。 （一）
-
-
-
-
-
-
-
-
-
搜索结果
73 条记录 (耗时 0.039 秒)
